According to the new report added by Research Beam the global biomarkers market for diagnostic applications will reach $30.6 billion in 2020 growing at CAGR of 16% from 2013 to 2020. http://www.researchbeam.com/biomarkers-market

Diagnostic biomarkers being important tool in molecular diagnostics, is facing challenges with respect to ethical and regulatory issues as these are related to genomic pattern of an individual which needs to be confidential.

The global biomarkers market for diagnostic applications such as risk assessment, molecular diagnostic, disease diagnosis, drug discovery & development, drug formulation, forensic and other such applications will reach $30.6 billion in 2020 growing at CAGR of 16% from 2013 to 2020. Disease diagnostic remains the key application segment that is anticipated to reach $6.1 billion in 2020. However application of diagnostic biomarkers in forensics and molecular diagnostics is catching up quite significantly with latter expected to experience a growth rate of 17.6% during 2013 and 2020.

Disease diagnosis, drug development and formulation, diagnosis for exposure of certain harmful chemical and prognostic treatments are few key segments that are increasing the adoption of biomarker technology. Biomarkers are novel diagnostic solutions and advancement in it its development and understanding of human genome promotes its application in diagnosis of disease on molecular basis. Pharmaceutical companies are increasing partnership and collaboration with private laboratories, educational institute and these companies are also increasing their investments in research and development for introducing novel diagnostic solution.

Diagnostic biomarkers being important tool in molecular diagnostics, is facing challenges with respect to ethical and regulatory issues as these are related to genomic pattern of an individual which needs to be confidential.

Global stem cell market is dominating the healthcare industry with its reliable and cost effective method of treatment with fewer side effects. Umbilical cord blood stem cells are one of the potential segments of stem cell market for growth in future. Other segments of this market include - Adult stem cell and embryonic stem cells.

One of the key reasons for adoption of flow cytometry technology is its precise deliverance of results comparing to conventional methods such as ELISA. The emergence of this technology as one of the leading applications has brought various advancements in the diagnosis of diseases such as HIV and cancer as well as in research fields.

New Frontiers in US Hematology and Flow Cytometry Markets: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new study designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the U.S. hematology and flow cytometry markets during the next five years.

Enteric disease is a condition caused in the intestine due to the presence of foreign antigen such as bacterial, viral and parasites. The enteric diseases are commonly caused due to E-coli, Vibro Cholerae salmonella, shigella, rotavirus, and norovirus. The most influencing factor being hygiene is getting worst due to the increasing population, especially in urban areas of developing economies. Several factors such as unsafe drinking water, poor sanitation and unhygienic conditions are increasing the prevalence of enteric diseases.

Research beam has large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. In order to survive the fierce competition and locate different avenues, one must be privy to high end and quality market information. So, we try and provide you with latest market information by getting high market research reports from our clients.